Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights
April 5, 4:31 PM
Gainers Longeveron (NASDAQ:LGVN) stock rose 48.6% to $3.27 during Friday’s after-market session. The company’s market cap stands at…

ADIL

Read More
4 minute read
  • Biotech
  • Events
  • General
  • News

Vor Bio Presents Data Update On Trem-cel At HSCT Conference; Primary Neutrophil Engraftment Of Trem-cel Achieved In All Seven Patients Treated To Date

By Benzinga Newsdesk
November 9, 5:49 PM
Primary neutrophil engraftment of trem-cel achieved in all seven patients treated to date All three patients receiving multiple Mylotarg™ doses exhibited hematologic protection, further validating Vor

VOR

Read More
5 minute read
  • Biotech
  • Events
  • General
  • News

Multiple Clinical And Preclinical Presentations At ASH 2023 Highlight Vor Bio’s Novel eHSC And CAR-T Platform

By Benzinga Newsdesk
November 2, 9:20 AM
Three oral and two poster presentations accepted by ASH Company to host call featuring Sarah K. Tasian, MD, Associate Professor of Pediatrics at the University of Pennsylvania School of Medicine and Chief of the

VOR

Read More
37 minute read
  • Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights
October 3, 2:37 PM
  On Tuesday, 647 companies set new 52-week lows.

AADI

Read More
28 minute read
  • Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights
September 21, 12:08 PM
  During the session on Thursday, 461 stocks hit new 52-week lows.

$TKO

Read More
17 minute read
  • Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights
September 19, 12:50 PM
  During Tuesday's session, 275 companies made new 52-week lows.

ABCL

Read More
2 minute read
  • Analyst Ratings

The Latest Analyst Ratings for Vor Biopharma

By Benzinga Insights
August 14, 12:00 PM
Analysts have provided the following ratings for Vor Biopharma (NASDAQ:VOR) within the last quarter: Bullish Somewhat Bullish Indifferent…

VOR

Read More
11 minute read
  • Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights
August 11, 2:01 PM
  During the Friday's sesion, 157 stocks hit new 52-week lows.

ABVC

Read More
9 minute read
  • Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights
August 10, 1:43 PM
  On Thursday, 128 companies set new 52-week lows.

ADAP

Read More
8 minute read
  • Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights
July 6, 12:58 PM
  On Thursday, 109 companies set new 52-week lows.

AADI

Posts pagination

1 2 … 4 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service